D. Lau-Corona, L. A. Pineda, H. H. Avilés, G. Gutiérrez-Reyes, B. E. Farfan-Labonne, R. Núñez-Nateras, A. Bonder, R. Martínez-García, C. Corona-Lau, M. A. Olivera-Martínez, M. C. Gutiérrez-Ruiz, G. Robles-Díaz, D. Kershenobich (2009). Effective use of FibroTest to generate decision trees in hepatitis C, World Journal of Gastroenterology June 7; 15(21): 2617-2622. DOI:10.3748/wjg.15.2617. ISSN:1007-9327

  1. P. Padugupati, “An Analysis and Survey on Artificial Neural Network Based Genetic Pattern Recognition for Predicting Hepatitis B and Hepatitis C Virus SRMAODV: a scalable reliable MAODV for MANET View project SRMAODV: a scalable reliable MAODV for MANET View project,” 2015.
  2. J. Luis Poo et al., “Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study,” Hepatol. Int., vol. 14, no. 5, pp. 817–827, Sep. 2020.
  3. А. Семенов, “Молекулярные и иммунологические маркеры повреждения печени при хронических вирусных гепатитах,” 2017.
  4. Houby, E. M. F. El. (2013). Analysis of Associative Classification for Prediction of HCV Response to Treatment.International Journal of Computer Applications Vol. 63, No. 15 pp. 38-44. https://duportal.in/download/175952-analysis-of-associative-classification-for-prediction-of-hcv-pdf
  5. Chirino-Sprung, R. A., Dehesa, M., Wolpert, E., Corona-Lau, C., García-Juarez, I., Sánchez-Ávila, J. F., … Kershenobich, D. (2016). Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting. Revista de Investigacion Clinica; Organo Del Hospital de Enfermedades de La Nutricion, 68(4), 203–212. Retrieved from www.clinicalandtranslationalinvestigation.com
  6. Enas M. F. El Houby, M. S. H. (2013). Comparison between Associative Classification and Decision Tree for HCV Treatment Response Prediction. International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering, 7(11). Retrieved from https://pdfs.semanticscholar.org/44eb/917dc461c2bbbc90be918285f26759dc219b.pdf
  7. Liu, F., Wei, L., Wang, S.-S., & Huang, B. (2016). Diagnostic Value of Transient Elastography Technology Combined with Serological Indicator for Liver Fibrosis in Patients with Chronic Hepatitis B. Chinese General Practice, 19(25), 3039–3044. https://doi.org/10.3969/j.issn.1007-9572.2016.25.008
  8. Eissa, M. M., Elmogy, M., Hashem, M., & Badria, F. A. (2015). Hybrid Rough Genetic algorithm model for making treatment decisions of hepatitis C. In ICET 2014 - 2nd International Conference on Engineering and Technology. https://doi.org/10.1109/ICEngTechnol.2014.7016784
  9. Sagnelli, E., Sagnelli, C., Pisaturo, M. A., Coppola, N., Pasquale, G., & Piccinino, F. (2012). Liver biopsy in chronic hepatitis C: The experience of 15 Italian wards of infectious diseases [Biopsia epatica nell’epatite cronica da HCV: Esperienza di 15 centri italiani di malattie infettive]. Infezioni in Medicina, 20(1), 31–36. Retrieved from https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859851521&partnerID=40&md5=fe29a8fd06f96025ba40f01606f36850 (155)
  10. Hassan, S., Syed, S., & Kehar, S. I. (2014). Review of diagnostic techniques of hepatic fibrosis. Journal of the Pakistan Medical Association, 64(8), 941–945. Retrieved from https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904718854&partnerID=40&md5=a4b3000283fba8210b3dd9b6e3eea242 (156)
  11. Eissa, M. M., Elmogy, M., & Hashem, M. (2014). Rough - Granular Neural Network Model for Making Treatment Decisions of Hepatitis C. In 2014 9TH INTERNATIONAL CONFERENCE ON INFORMATICS AND SYSTEMS (INFOS).
  12. Eissa, M. M., Elmogy, M., & Hashem, M. (2015). Rough-Granular neural network model for making treatment decisions of Hepatitis C. In 2014 9th International Conference on Informatics and Systems, INFOS 2014 (pp. DEKM19–DEKM26). https://doi.org/10.1109/INFOS.2014.7036703
  13. El Houby, E. M. F., & Hassan, M. S. (2012). Using associative classification for treatment response prediction. Journal of Applied Sciences Research, 8(10), 5089–5095. Retrieved from https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872540420&partnerID=40&md5=5ecb0a518cbf5633ca00df8d65f7cd48

CITAS DE CO-AUTORES

D. Kershenobich, N. F.-H. B. and C, and undefined 2019, “Challenges and strategies for access to treatment of hepatitis C in Latin America,” books.google.com.